- Home
- ROIV vs BZ Comparison
ROIV vs BZ Comparison
Compare ROIV & BZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- BZ
- Stock Information
- Founded
- ROIV 2014
- BZ 2013
- Country
- ROIV United Kingdom
- BZ China
- Employees
- ROIV N/A
- BZ N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- BZ Computer Software: Programming Data Processing
- Sector
- ROIV Health Care
- BZ Technology
- Exchange
- ROIV Nasdaq
- BZ Nasdaq
- Market Cap
- ROIV 8.4B
- BZ 6.9B
- IPO Year
- ROIV N/A
- BZ 2021
- Fundamental
- Price
- ROIV $11.01
- BZ $14.36
- Analyst Decision
- ROIV Buy
- BZ Buy
- Analyst Count
- ROIV 4
- BZ 5
- Target Price
- ROIV $17.50
- BZ $20.20
- AVG Volume (30 Days)
- ROIV 7.5M
- BZ 5.9M
- Earning Date
- ROIV 05-29-2025
- BZ 05-20-2025
- Dividend Yield
- ROIV N/A
- BZ N/A
- EPS Growth
- ROIV N/A
- BZ 42.62
- EPS
- ROIV N/A
- BZ 0.48
- Revenue
- ROIV $122,585,000.00
- BZ $1,007,751,228.00
- Revenue This Year
- ROIV N/A
- BZ $15.99
- Revenue Next Year
- ROIV N/A
- BZ $13.29
- P/E Ratio
- ROIV N/A
- BZ $30.62
- Revenue Growth
- ROIV 140.04
- BZ 23.58
- 52 Week Low
- ROIV $8.73
- BZ $10.57
- 52 Week High
- ROIV $13.06
- BZ $22.74
- Technical
- Relative Strength Index (RSI)
- ROIV 62.83
- BZ 37.24
- Support Level
- ROIV $9.90
- BZ $13.28
- Resistance Level
- ROIV $10.26
- BZ $14.84
- Average True Range (ATR)
- ROIV 0.45
- BZ 0.96
- MACD
- ROIV 0.16
- BZ -0.06
- Stochastic Oscillator
- ROIV 93.06
- BZ 34.29
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About BZ KANZHUN LIMITED American Depository Shares
Kanzhun's Boss Zhipin job platform connects job seekers and employers. Boss Zhipin is China's largest online recruitment platform based on average number of monthly active users, or MAU, and was established in 2014. Kanzhun earns revenue by providing services to enterprise customers primarily through its mobile app, which promotes engagement between recruiters and workers and operates on a recommendation basis powered by artificial intelligence. The platform specializes in transportation, logistics, construction, and service-based industries. About 85% of the companies looking to hire are small and medium-size enterprises. Its main competitors are 58.com, 51job, and Zhilian Zhaopin. Tencent has a 9.2% stake in Kanzhun.